MENU
ANNX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Annexon (ANNX) Ownership - Who owns Annexon?
Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye... Show more
Profile
Industry
N/A
Address
1400 Sierra Point Parkway
Phone
+1 650 822-5500
Employees
71
Web
https://www.annexonbio.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
198.57M
P/E Ratio
N/A
Total Cash
312.02M
Projected Growth
N/A
Total Debt
28.97M
Revenue
N/A
Risk (Beta)
1.20
Dividend Yield
N/A
Total Cash/Share
2.84
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
ANNX
Capitalization
199M
P/E Ratio
N/A
Risk (Beta)
1.20
Dividend Yield
N/A
Total Cash
312M
Total Cash/Share
2.84
Total Debt
29M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
293M
P/B Ratio
0.73
Cash Flow
N/A
Earnings
-1.01
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
109K
Current Ratio
10.37
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-151.48M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-42.67
Shares Held By Institutions
787M
Shares Outstanding - Current
110M
Total Liabilities
57M
Total Volume MTD
N/A
Value
1
Gain YTD
-64.717
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a clinical-stage biopharmaceutical company, which develops a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, eye and brain
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
1400 Sierra Point Parkway
Phone
+1 650 822-5500
Employees
71
Web
https://www.annexonbio.com